Drug name - Solodyn

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8722650 BAUSCH Extended-release minocycline dosage forms Jun, 2025

(2 years from now)

US8252776 BAUSCH Minocycline oral dosage forms for the treatment of acne Jun, 2025

(2 years from now)

US8268804 BAUSCH Minocycline oral dosage forms for the treatment of acne Jun, 2025

(2 years from now)

US7790705 BAUSCH Minocycline oral dosage forms for the treatment of acne Jun, 2025

(2 years from now)

US7919483 BAUSCH Method for the treatment of acne Mar, 2027

(4 years from now)

US7544373 BAUSCH Minocycline oral dosage forms for the treatment of acne Apr, 2027

(4 years from now)

US7541347 BAUSCH Minocycline oral dosage forms for the treatment of acne Apr, 2027

(4 years from now)

US9192615 BAUSCH Method for the treatment of acne and certain dosage forms thereof Nov, 2031

(9 years from now)

Drugs and Companies using MINOCYCLINE HYDROCHLORIDE ingredient

Treatment: Treatment of acne; Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
EQ 45MG BASE TABLET, EXTENDED RELEASE;ORAL Discontinued
EQ 55MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription
EQ 65MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription
EQ 80MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription
EQ 90MG BASE TABLET, EXTENDED RELEASE;ORAL Discontinued
EQ 105MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription
EQ 115MG BASE TABLET, EXTENDED RELEASE;ORAL Prescription
EQ 135MG BASE TABLET, EXTENDED RELEASE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.